340B In The News

Bloomberg Law: Drug Lobby Spends Record Amount in Fight Over Medicine Costs

“The main lobbying association for drug makers, the Pharmaceutical Research and Manufacturers of America, spent a record $28.9 million on lobbying last year as it pushed back on legislation meant ...

Utility Dive: Providers push back on PhRMA report highlighting 340B program costs

“The hospital industry pushed back on the findings, the latest salvo in an ongoing battle over the program, which provider trade groups like the American Hospital Association and America’s Essential ...

340B may curb high drug prices, new JAMA study finds

The 340B drug pricing program may discourage drug manufacturers from raising prices and instead may have the effect of reducing list prices for certain drugs. That’s according to a new study published ...

Managed Healthcare Executive: 340B Program Helps Rural Hospitals Stay Afloat

“Rural hospitals are facing a crisis, as many close or struggle to stay on top of rising expenses. But a new study shows that savings from the 340B drug pricing program are ...

Becker’s Hospital Review: 340B saves hospitals an average $11.8M per year, report finds

“Hospitals participating in the 340B drug discount program saved an average of $11.8 million per year, according to a new report from 340B Health. For its annual report, released in ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields